Glomerulonephritis disease pattern at Saudi tertiary care center

References

1. ↵
   1. USRDS

   2015 USRDS Annual Data Report Volume 2: ESRD in the United States, Available from: https://www.usrds.org/2015/download/vol2_USRDS_ESRD_15.pdf. [Cited 2017 January 1].
2. ↵
   1. SCOT

   (2015) Saudi Center for Organ Transplantation. 2015 Annual Report, Available from: http://www.scot.gov.sa/Pages/Doc15.aspx?loc=219&loc2=118. [Cited 2017 January 1].
3. ↵
   1. Huraib S,
   2. Al Khader A,
   3. Shaheen FA,
   4. Abu Aisha H,
   5. Souqiyyeh MZ,
   6. Al Mohana F,
   7. et al.

   (2000) The spectrum of glomerulonephritis in saudi arabia: the results of the saudi registry. Saudi J Kidney Dis Transpl 11:434–441.

   OpenUrlPubMed
4. ↵
   1. Jalalah S

   (2009) Patterns of primary glomerular diseases among adults in the western region of Saudi Arabia. Saudi J Kidney Dis Transpl 20:295–299.

   OpenUrlPubMed
5. ↵
   1. Al Wakeel JS,
   2. Mitwalli AH,
   3. Tarif N,
   4. Alam AA,
   5. Hammad D,
   6. Abu-Aisha H,
   7. et al.

   (2004) Spectrum and outcome of primary glomerulonephritis. Saudi J Kidney Dis Transpl 15:440–446.

   OpenUrlPubMed
6. ↵
   1. Nawaz Z,
   2. Mushtaq F,
   3. Mousa D,
   4. Rehman E,
   5. Sulaiman M,
   6. Aslam N,
   7. et al.

   (2013) Pattern of glomerular disease in the Saudi population: A single-center, five-year retrospective study. Saudi J Kidney Dis Transpl 24:1265–1270.

   OpenUrl
7. ↵
   1. Sim JJ,
   2. Batech M,
   3. Hever A,
   4. Harrison TN,
   5. Avelar T,
   6. Kanter MH,
   7. et al.

   (2016) Distribution of biopsy-proven presumed primary glomerulonephropathies in 2000-2011 among a racially and ethnically diverse US population. Am J Kidney Dis 68:533–544.

   OpenUrlPubMed
8. ↵
   1. Vizjak A,
   2. Ferluga D,
   3. Rozic M,
   4. Hvala A,
   5. Lindic J,
   6. Levart TK,
   7. et al.

   (2008) Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 19:2237–2244.

   OpenUrlAbstract/FREE Full Text
9. ↵
   1. Devasahayam J,
   2. Erode-Singaravelu G,
   3. Bhat Z,
   4. Oliver T,
   5. Chandran A,
   6. Zeng X,
   7. et al.

   (2015) C1q Nephropathy: The Unique Underrecognized Pathological Entity. Anal Cell Pathol (Amst) 2015:490413.

   OpenUrl
10. ↵
    1. Albishri J,
    2. Alshehri S,
    3. Altowairqi A,
    4. Aljuaid R

    (2015) Familial lupus and clinical characteristics in Saudi Arabia. International Journal of Clinical Medicine 6:899–905.

    OpenUrl
11. ↵
    1. Abid N,
    2. Khan AS,
    3. Al Otaibi FH

    (2013) Systemic lupus erythematosus (SLE) in the eastern region of Saudi Arabia. A comparative study. Lupus 22:1529–1533.

    OpenUrlCrossRefPubMed
12. ↵
    1. Al Arfaj AS,
    2. Khalil N,
    3. Al Saleh S

    (2009) Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia. Rheumatol Int 29:1057–1067.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Khan A,
    2. Abid N,
    3. Khawaja R

    (2016) Clinical continuum of spstemic lupus in Saudi Arabia. Lupus Open Access 1:1000113.

    OpenUrl
14. ↵
    1. Al Arfaj AS,
    2. Khalil N

    (2009) Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus 18:465–473.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Haas M,
    2. Rastaldi MP,
    3. Fervenza FC

    (2014) Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification. Kidney Int 86:648.

    OpenUrl
16. ↵
    1. Sethi S,
    2. Haas M,
    3. Markowitz GS,
    4. D'Agati VD,
    5. Rennke HG,
    6. Jennette JC,
    7. et al.

    (2016) Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN. J Am Soc Nephrol 27:1278–1287.

    OpenUrlAbstract/FREE Full Text
17. ↵
    1. Mubarak M

    (2012) Oxford classification of IgA nephropathy: Broadening the scope of the classification. J Nephropathol 1:13–16.

    OpenUrlPubMed
18. ↵
    1. Nasri H,
    2. Mortazavi M,
    3. Ghorbani A,
    4. Shahbazian H,
    5. Kheiri S,
    6. Baradaran A,
    7. et al.

    (2012) Oxford-MEST classification in IgA nephropathy patients: A report from Iran. J Nephropathol 1:31–42.

    OpenUrlCrossRefPubMed
19. ↵
    1. O'Shaughnessy MM,
    2. Hogan SL

    (2016) Distinguishing the Signals From the Noise: Can Epidemiologic Studies Inform Our Understanding of Glomerular Disease? Am J Kidney Dis 68:503–507.

    OpenUrl